Enhancement of Cisplatin Sensitivity in Human Cervical Cancer: Epigallocatechin-3-Gallate

Frontiers in Nutrition

Volumn 1, Issue , 2015, Pages

  Kilic, Ulkan ^a   Sahin, Kazim ^b   Tuzcu, Mehmet ^b   Basak, Nazli ^c   Orhan, Cemal ^b   Elibol Can, Birsen ^d   Kilic, Ertugrul ^a   Sahin, Fikrettin ^c   Kucuk, Omer ^e  

^a ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^e EMORY UNIVERSITY   (United States)

Author keywords

cisplatin; epigallocatechin gallate; HeLa cells; human cervical cancer; sensitization

Indexed keywords

EID: 84988443152     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2014.00028     Document Type: Article

References (33)

1. Ho YP, Au-Yeung SC, To KK. Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med Res Rev (2003) 23:633–55.10.1002/med.1003812789689
2. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol (2003) 23:460–4.10.1016/S0270-9295(03)00089-513680535
3. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med (1998) 131:518–26.10.1016/S0022-2143(98)90060-99626987
4. Kuroda Y, Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res (1999) 436:69–97.10.1016/S1383-5742(98)00019-2
5. Mukhtar H, Ahmad N. Green tea in chemoprevention of cancer. Toxicol Sci (1999) 52:111–7.10.1093/toxsci/52.suppl_1.111
6. Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, et al. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther (2003) 307:230–6.10.1124/jpet.103.05467612954803
7. Qiao Y, Cao J, Xie L, Shi X. Cell growth inhibition and gene expression regulation by (2)-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res (2009) 32:1309–15.10.1007/s12272-009-1917-319784588
8. Hsieh TC, Wu JM. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res (2009) 29:4025–32.19846946
9. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol (2004) 24:703–10.10.3892/ijo.24.3.70314767556
10. Sadava D, Whitlock E, Kane S. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun (2007) 360:233–7.10.1016/j.bbrc.2007.06.03017585882
11. Mimoto J, Kiura K, Matsuo K, Yoshino T, Takata I, Ueoka H. (–)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis (2000) 21:915–9.10.1093/carcin/21.5.91510783312
12. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol (2008) 46:1271–8.10.1016/j.fct.2007.10.00618082923
13. Chan MM, Soprano KJ, Weinstein K, Fong D. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol (2006) 207:389–96.10.1002/jcp.2056916402374
14. Singh R, Akhtar N, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci (2010) 86:907–18.10.1016/j.lfs.2010.04.01320462508
15. Sahin K, Tuzcu M, Gencoglu H, Dogukan A, Timurkan M, Sahin N, et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci (2010) 87:240–5.10.1016/j.lfs.2010.06.01420619277
16. Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol (2006) 72:1439–52.10.1016/j.bcp.2006.07.004
17. Singh M, Bhui K, Singh R, Shukla Y. Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sci (2013) 93:7–16.10.1016/j.lfs.2013.02.00123399702
18. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods (1986) 89:271–7.10.1016/0022-1759(86)90368-63486233
19. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res (2006) 66:3347–50.10.1158/0008-5472.CAN-05-452616585150
20. Kilic U, Kilic E, Tuzcu Z, Tuzcu M, Ozercan IH, Yilmaz O, et al. Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond) (2013) 10:7.10.1186/1743-7075-10-723311701
21. Sahin K, Tuzcu M, Basak N, Caglayan B, Kilic U, Sahin F, et al. Sensitization of cervical cancer cells to cisplatin by genistein: the role of NFκB and Akt/mTOR signaling pathways. J Oncol (2012) 2012:461562.10.1155/2012/46156223056046
22. Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR. Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells. Int J Oncol (2013) 43:194–200.10.3892/ijo.2013.192023615977
23. Lee SH, Nam HJ, Kang HJ, Kwon HW, Lim YC. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. Eur J Cancer (2013) 49:3210–8.10.1016/j.ejca.2013.06.02523876835
24. Ji J, Zheng PS. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells. Gynecol Oncol (2010) 117:103–8.10.1016/j.ygyno.2009.12.02020102778
25. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol (2009) 61:223–42.10.1016/j.etp.2008.09.00318986801
26. Kweon MH, Adhami VM, Lee JS, Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem (2006) 281:33761–72.10.1074/jbc.M60474820016950787
27. Sriram N, Kalayarasan S, Sudhandiran G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther (2009) 22:221–36.10.1016/j.pupt.2008.12.01019138753
28. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res (2008) 58:262–70.10.1016/j.phrs.2008.09.003
29. Godwin P, Baird AM, Heavey S, Barr MP, O’Byrne KJ, Gately K. Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front Oncol (2013) 3:120.10.3389/fonc.2013.0012023720710
30. Oiso S, Ikeda R, Nakamura K, Takeda Y, Akiyama S, Kariyazono H. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells. Oncol Rep (2012) 28:27–32.10.3892/or.2012.180122562377
31. Almeida LO, Abrahao AC, Rosselli-Murai LK, Giudice FS, Zagni C, Leopoldino AM, et al. NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio (2013) 4:96–104.10.1016/j.fob.2013.12.00324490130
32. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol (2001) 2:544–51.10.1016/S1470-2045(01)00488-011905709
33. Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol (2001) 62:1175–83.10.1016/S0006-2952(01)00767-511705450